Announcement on Returning Idle Raised Funds Used for Temporarily Supplementing Current Capital
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
Announcement on Returning Idle Raised Funds Used for Temporarily Supplementing Current Capital
Filed with SSE · · 1 page · Chinese
Release
Vcanbio Cell & Gene Engineering Corp., Ltd. on 6ix
Earlier from Vcanbio Cell & Gene Engineering
- Announcement on the Resignation of Deputy General Manager and Secretary of the Board of Directors
- Announcement on Returning Idle Raised Funds for Cash Management to Special Account for Raised Funds
- Announcement on Signing Property Service Entrustment Contract and Related Transactions between Holding Subsidiaries and Tianjin Hongkan Property Operation Management Co., Ltd.
- Announcement on Obtaining Notice of Acceptance for Drug Clinical Trial Application of the Wholly-owned Subsidiary
- Announcement on Using Temporarily Idle Raised Funds and Self-owned Funds for Cash Management
Later from Vcanbio Cell & Gene Engineering
- Announcement on Change of Accounting Policies
- Announcement on Convening the 2024 Annual Performance Briefing
- Announcement on Resolution of the 2024 Annual General Meeting
- Announcement on Resolution of the 9th Extraordinary Meeting of the 11th Board of Supervisors
- Announcement on Wholly-owned Subsidiary Obtaining Notice of Acceptance of Application for Drug Clinical Trial
Follow Vcanbio Cell & Gene Engineering into a list and get an email when it puts out news.
Follow Vcanbio Cell & Gene Engineering